CompletedPhase 1

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

NCT02640092

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Molecular NeuroImaging

New Haven, Connecticut, United States

+15 additional locations

Save this trial

Molecular NeuroImagingNew Haven, Connecticut, United States
KI Health Partners, LLC; New England Institute for Clinical ResearchStamford, Connecticut, United States
Neuropsychiatric Research; Center of Southwest FloridaFort Myers, Florida, United States
Miami Jewish Health SystemsMiami, Florida, United States
Bioclinica ResearchOrlando, Florida, United States
Emory UniversityAtlanta, Georgia, United States
NeuroStudies.net, LLCDecatur, Georgia, United States
Acadia Clinical Research; Dr. Henderson's OfficeBangor, Maine, United States
Donald S. Marks, M.D., P.C.; Medical CenterPlymouth, Massachusetts, United States
Alzheimers Disease CenterQuincy, Massachusetts, United States
NeuroCognitive InstituteMount Arlington, New Jersey, United States
Bio Behavioral HealthToms River, New Jersey, United States
Advanced Medical ResearchMaumee, Ohio, United States
Lehigh Center Clinical ResearchAllentown, Pennsylvania, United States
Rhode Island Mood & Memory Research InstituteEast Providence, Rhode Island, United States
Butler HospitalProvidence, Rhode Island, United States